The inhibition of the protein Gm13526 can be achieved through the use of various chemical inhibitors, each with a distinct mechanism of action. These inhibitors target specific aspects of Gm13526's functionality, either directly or indirectly, by influencing related cellular pathways. One group of inhibitors, including Etoposide and Paclitaxel, operates through direct interaction with Gm13526. Etoposide, for instance, induces DNA damage and interferes with topoisomerase II, a crucial protein involved in DNA replication and repair. This disruption ultimately leads to protein dysfunction, inhibiting Gm13526's capacity to perform its cellular functions effectively. Similarly, Paclitaxel disrupts microtubule dynamics, thereby affecting the cellular transport processes in which Gm13526 participates. This disruption in transport hinders Gm13526's involvement in vital cellular processes, contributing to its inhibition.
Other inhibitors, such as Cisplatin and Wortmannin, indirectly affect Gm13526 by targeting specific signaling pathways associated with the protein. Cisplatin forms DNA adducts, causing structural distortions in DNA, which can disrupt processes related to Gm13526 indirectly. Wortmannin, on the other hand, is a specific PI3K inhibitor that affects a signaling pathway associated with Gm13526. By inhibiting this pathway, Wortmannin indirectly leads to the inhibition of Gm13526's function. These indirect mechanisms showcase the complexity of inhibiting Gm13526, highlighting the diversity of chemical compounds that can effectively hinder its cellular activities. In summary, the inhibition of Gm13526 can be achieved through a diverse array of chemical inhibitors, each with its unique mode of action. These inhibitors target Gm13526 either directly, by interfering with its structure or function, or indirectly, by influencing the signaling pathways and cellular processes in which it participates. The variety of chemical inhibitors presented here demonstrates the potential for modulating Gm13526's activity, providing valuable insights into the regulation of this protein in cellular contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits Gm13526 by inducing DNA damage and interfering with topoisomerase II, a protein essential for DNA replication and repair, leading to protein dysfunction. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol disrupts microtubule dynamics, affecting Gm13526's cellular transport, ultimately inhibiting its function in cellular processes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts, causing DNA structural distortions, which can indirectly inhibit Gm13526 by disrupting DNA-related processes it is involved in. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a specific PI3K inhibitor, affecting a signaling pathway associated with Gm13526, leading to the indirect inhibition of the protein. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits Gm13526 by disrupting calcium homeostasis in cells, which affects signaling pathways in which the protein is involved. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a protein downstream of pathways related to Gm13526, leading to the indirect inhibition of Gm13526's function. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that can indirectly inhibit Gm13526 by affecting protein kinases in related pathways. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil interferes with nucleotide synthesis and DNA replication, potentially indirectly inhibiting Gm13526 through disrupted cellular processes. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, impacting the folate pathway and indirectly affecting cellular processes related to Gm13526. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB-431542 inhibits the TGF-β receptor kinase, which is part of signaling pathways involving Gm13526, leading to the indirect inhibition of the protein. | ||||||